Gutierrez Wealth Advisory’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$670K Buy
1,589
+95
+6% +$37.9K 0.36% 42
2026
Q2
$541K Buy
1,494
+16
+1% +$5.48K 0.31% 37
2026
Q1
$520K Buy
1,478
+49
+3% +$17.5K 0.32% 35
2025
Q4
$468K Buy
1,429
+20
+1% +$6.34K 0.29% 37
2025
Q3
$398K Sell
1,409
-14
-1% -$4.06K 0.25% 38
2025
Q2
$397K Sell
1,423
-58
-4% -$16.4K 0.27% 37
2025
Q1
$461K Buy
1,481
+262
+21% +$77.4K 0.37% 24
2024
Q4
$318K Buy
+1,219
New +$362K 0.26% 33

Other funds holding AMGN

Gutierrez Wealth Advisory's AMGN Position: Q3 2026 in Review

Gutierrez Wealth Advisory increased its Amgen (AMGN) stake by 6.4% in Q3 2026, buying an estimated $37.9K and bringing the position to 1,589 shares worth $670K. The position accounts for 0.36% of the portfolio, ranked #42.

Gutierrez Wealth Advisory first reported a position in AMGN in Q4 2024 and has held it in 8 quarters since. 2,024 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Gutierrez Wealth Advisory held 1,589 shares of Amgen worth $670K as of Q3 2026.
  • Gutierrez Wealth Advisory bought 95 Amgen shares in Q3 2026, an estimated $37.9K.
  • Amgen made up 0.36% of Gutierrez Wealth Advisory's portfolio in Q3 2026, its #42 holding.
  • Gutierrez Wealth Advisory first reported a position in Amgen in Q4 2024 and has held it in 8 quarters since.
  • 2,024 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Gutierrez Wealth Advisory's 13F filing for Q3 2026, filed 2 Nov 2026.